Register to receive a free US Orthopedic Large Joint Device Market Report Suite 2018-2024 synopsis and brochure

OrthoSensor, Inc., a leader in sensor-assisted technology for total knee replacement (TKR), announced it has received 510(K) clearance from the U.S. Food and Drug Administration (FDA) for its VERASENSE* Sensor-Assisted Technology (VERASENSE) to be used with Zimmer Biomet’s Persona Knee System for total knee replacement.

VERASENSE harnesses the latest innovations in sensors and wireless communications for primary and revision total knee replacement (TKR) during surgery, with the goals of improving patient outcomes and satisfaction.

Said Ivan Delevic, President and Chief Executive Officer of OrthoSensor, Inc.: “Receiving FDA clearance for VERASENSE use with the Zimmer Biomet Persona Knee System, augments this outstanding implant and instrumentation, securing a better balanced knee after surgery.  The VERASENSE device brings real-time, quantified soft tissue balance data to our surgeons.  This evidenced-based data regarding soft tissue balance works with systems such as Persona so that surgeons can make objective assessments intraoperatively, resulting in better clinical outcomes for patients.”

Earlier this year, OrthoSensor received clearance to use VERASENSE with the Persona Knee System in Australia.   Dr. Lachlan Host from Bathurst Private Hospital in Australia successfully used VERASENSE for Persona Knee System for the first time. Dr. Host said, “Using VERASENSE has completely changed my joint arthroplasty practice. Since using VERASENSE, I have found patients have consistently improved range of motion and have had less focal pain. I now know, irrefutably, that I am achieving improved patient outcomes.”

Historically, roughly one in every five TKR patients (~20%) is dissatisfied with the results of their surgery. Common patient complaints include persistent pain, instability, stiffness, and loss in range of motion. Before VERASENSE; surgeons generally relied on their “best judgment” in determining what “felt” like a balanced knee.

The subjectivity of total knee replacement, coupled with improper soft tissue balance and implant position, may result in premature implant failure and the need for revision surgery in the future.

In a prospective multi-center study, VERASENSE use was proven to reduce post-operative pain, accelerate patient activity levels, improve functional outcomes, and increase patient satisfaction scores with high statistical significance. In fact, 98 percent of patients whose knees were balanced using VERASENSE reported they were satisfied to very satisfied at three years post-op. These proven results point to improved joint balance being the key to higher TKR satisfaction.

About OrthoSensor, Inc.

OrthoSensor, Inc., a leader in Sensor-Assisted Total Knee Arthroplasty, develops and commercializes intelligent orthopedic devices and data services that provide quantitative feedback to surgeons and hospitals.  The company’s intelligent orthopaedic devices utilize advanced proprietary sensor and communications technologies, coupled with the company’s innovative software products, to facilitate evidence-based decisions in orthopaedic surgery – with the goal of improving patient outcomes and potentially reducing the cost of treating musculoskeletal disease.

Source: https://www.prnewswire.com/news-releases/orthosensor-inc-secures-additional-510k-clearance-300662461.html

For Further Information

More on the orthopedic large joints replacement market in the U.S. can be found in a series of reports published by iData entitled the U.S. Market Report Suite for Orthopedic Large Joint Devices. This report covers the following market segments: hip implants, knee implants, and bone cement.

The iData series on the market for orthopedic large joint devices covers the U.S., India, Japan, China,  and 15 countries in Europe including Germany, France, the United Kingdom (U.K.), Italy, Spain, Benelux (Belgium, Netherlands and Luxemburg), Scandinavia (Finland, Denmark, Sweden and Norway), Portugal, Austria and Switzerland. Reports provide a comprehensive analysis including units sold, procedure numbers, market value, forecasts, as well as detailed competitive market shares and analysis of major players’ success strategies in each market and segment. To find out more about orthopedics large joint replacement market data or procedure data, register online or email us at [email protected] for an U.S. Market Report Suite for Orthopedic Large Joint Devices brochure and synopsis